DOCSLIB.ORG

Supplemental Figure 2.Eps

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Androgen Resveratrol 75uM 150uM 43h-10nM 43h-100nM 43h-1uM 20h-10uM 18h-25uM 20h-40uM 20h-100uM 0h 1h 3h 6h 9h 12h 15h 18h 21h 24h 48h 60h 0h 1h 2h 3h 4h 6h 8h 12h 14h 16h 18h 20h 22h 24h 48h 60h 7h-R1881 9h-R1881 18h-R1881 24h-R1881 50h-R1881 72h-R1881 18h-DHT10 50h-DHT10 24h-DHT100 24h-DHT1000 46h-noR1881 70h-noR1881 99855 ZFH4 zinc finger homeodomain 4 Hs.109314 105366 NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 p105 Hs.83428 112015 SEPT6 septin 6 Hs.90998 111438 SLC12A2 **solute carrier family 12 sodium/potassium/chloride transporters, member 2 Hs.110736 117460 ZIC2 Zic family member 2 odd-paired homolog, Drosophila Hs.132863 112768 KIAA0914 KIAA0914 gene product Hs.177664 111066 ESTs, Weakly similar to GNMSLL retrovirus-related reverse transcriptase homolog - mouse retrotransposon [M.musculus] Hs.301451 104992 FN1 fibronectin 1 Hs.287820 116170 RDC1 G protein-coupled receptor Hs.23016 99709 PDCD5 programmed cell death 5 Hs.166468 112624 CTBP1 C-terminal binding protein 1 Hs.239737 118259 GRB10 growth factor receptor-bound protein 10 Hs.81875 111378 PURA purine-rich element binding protein A Hs.29117 120755 **ESTs, Weakly similar to CNG1_HUMAN cGMP-gated cation channel alpha 1 CNG channel alpha 1 CNG-1 CNG1 Cyclic nucleotide gated channel alpha 1 Cyclic nucleotide gated channel, photoreceptor Hs.356525 118729 DKFZP564D0462 hypothetical protein DKFZp564D0462 Hs.44197 101077 LRBA vesicle trafficking, beach and anchor containing Hs.62354 116608 BTD biotinidase Hs.78885 107627 BCHE butyrylcholinesterase Hs.1327 114310 C14orf4 chromosome 14 open reading frame 4 Hs.179260 116521 MGC2306 hypothetical protein MGC2306 Hs.760 109427 KIAA1497 KIAA1497 protein Hs.126085 101321 Homo sapiens cDNA: FLJ21409 fis, clone COL03924 Hs.172129 99119 PURA purine-rich element binding protein A Hs.29117 119924 **ESTs, Highly similar to AF191653_1 diphosphoinositol polyphosphate phosphohydrolase type 2 beta [Homo sapiens] [H.sapiens] Hs.356699 111856 Homo sapiens cDNA FLJ30223 fis, clone BRACE2001785 Hs.13291 105685 ABLIM actin binding LIM protein Hs.158203 102756 ESTs Hs.94309 114857 PLA2G2A phospholipase A2, group IIA platelets, synovial fluid Hs.76422 114140 LOC51205 LPAP for lysophosphatidic acid phosphatase Hs.15871 112607 PRO1489 hypothetical protein PRO1489 Hs.197922 105918 PRO1489 hypothetical protein PRO1489 Hs.197922 106874 PRO1489 hypothetical protein PRO1489 Hs.197922 115634 ADD3 adducin 3 gamma Hs.324470 109351 HIBADH 3-hydroxyisobutyrate dehydrogenase Hs.284170 116434 NET1 neuroepithelial cell transforming gene 1 Hs.25155 119334 Homo sapiens cDNA: FLJ23324 fis, clone HEP12482, highly similar to HUMMYOHCB Human nonmuscle myosin heavy chain-B MYH10 mRNA Hs.296842 119341 ZNF297B zinc finger protein 297B Hs.127649 110323 KIAA1218 KIAA1218 protein Hs.114012 116861 WAC **WW domain-containing adapter with a coiled-coil region Hs.70333 108895 CCNG2 cyclin G2 Hs.79069 112189 Homo sapiens prostate-specific membrane antigen PSM mRNA, exon 6 alternative splice variant, partial cds Hs.283946 110198 UTX ubiquitously transcribed tetratricopeptide repeat gene, X chromosome Hs.13980 101131 Homo sapiens mRNA; cDNA DKFZp586J2118 from clone DKFZp586J2118 Hs.21851 109255 Homo sapiens mRNA; cDNA DKFZp586J2118 from clone DKFZp586J2118 Hs.21851 98389 Homo sapiens mRNA; cDNA DKFZp586J2118 from clone DKFZp586J2118 Hs.21851 98724 LOC51313 AD021 protein Hs.323583 108454 Homo sapiens cDNA FLJ13136 fis, clone NT2RP3003139 Hs.106795 105869 Homo sapiens, Similar to zinc finger protein 91 HPF7, HTF10, clone MGC:26916 IMAGE:4837196, mRNA, complete cds Hs.180546 108074 LOC51313 **AD021 protein Hs.323583 102400 CDW92 CDw92 antigen Hs.179902 109323 Homo sapiens, clone MGC:27375 IMAGE:4688423, mRNA, complete cds Hs.293782 116741 DDEF2 development and differentiation enhancing factor 2 Hs.12802 120095 ESTs Hs.355581 112577 ATP11A ATPase, Class VI, type 11A Hs.29189 99993 PIK3R3 phosphoinositide-3-kinase, regulatory subunit, polypeptide 3 p55, gamma Hs.372548 115229 Homo sapiens cDNA FLJ13182 fis, clone NT2RP3004070 Hs.210706 114093 FZD3 frizzled 3 Hs.40735 110643 Homo sapiens mRNA; cDNA DKFZp586F1223 from clone DKFZp586F1223 Hs.28540 120807 MGC3032 hypothetical protein MGC3032 Hs.300383 100750 SLC20A2 solute carrier family 20 phosphate transporter, member 2 Hs.347527 120838 TRPS1 trichorhinophalangeal syndrome I Hs.26102 105985 TUSP tubby super-family protein Hs.102237 115614 MMP16 matrix metalloproteinase 16 membrane-inserted Hs.90800 99531 SPUVE protease, serine, 23 Hs.25338 108855 CA12 carbonic anhydrase XII Hs.5338 117506 GSTA2 **glutathione S-transferase A2 Hs.378199 114709 KIF5B kinesin family member 5B Hs.149436 107947 ESTs Hs.356032 111802 FLJ10846 hypothetical protein FLJ10846 Hs.32271 107589 LOC90355 hypothetical gene supported by AF038182; BC009203 Hs.25925 119133 COL5A2 collagen, type V, alpha 2 Hs.82985 112279 FLJ13110 hypothetical protein FLJ13110 Hs.7358 118078 KIAA0379 KIAA0379 protein Hs.32556 99229 EPS8 epidermal growth factor receptor pathway substrate 8 Hs.2132 98916 ENO2 enolase 2, gamma, neuronal Hs.146580 113637 SERPINI1 serine or cysteine proteinase inhibitor, clade I neuroserpin, member 1 Hs.78589 113533 COLEC12 collectin sub-family member 12 Hs.29423 101216 SSBP2 single-stranded DNA binding protein 2 Hs.169833 112769 ESTs Hs.180197 102433 DPYSL2 dihydropyrimidinase-like 2 Hs.173381 98994 RALGPS1A Ral guanine nucleotide exchange factor RalGPS1A Hs.374518 105391 **Homo sapiens cDNA FLJ39156 fis, clone OCBBF2002015 Hs.376140 119998 PHRET1 PH domain containing protein in retina 1 Hs.1787 107210 CDK8 cyclin-dependent kinase 8 Hs.25283 114197 OCLN occludin Hs.171952 101389 ATP2B1 **ATPase, Ca++ transporting, plasma membrane 1 Hs.78546 103482 PKIB protein kinase cAMP-dependent, catalytic inhibitor beta Hs.106106 117682 KIAA0247 KIAA0247 gene product Hs.82426 107778 PA26 p53 regulated PA26 nuclear protein Hs.14125 119919 FLJ22569 hypothetical protein FLJ22569 Hs.234355 112086 SART2 squamous cell carcinoma antigen recognized by T cell Hs.58636 104594 ENPP5 ectonucleotide pyrophosphatase/phosphodiesterase 5 putative function Hs.35198 117183 TLE3 transducin-like enhancer of split 3 Esp1 homolog, Drosophila Hs.287362 100719 TLE3 transducin-like enhancer of split 3 Esp1 homolog, Drosophila Hs.287362 113958 TLE3 transducin-like enhancer of split 3 Esp1 homolog, Drosophila Hs.287362 117005 PIK3R1 phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 p85 alpha Hs.6241 120553 BARD1 BRCA1 associated RING domain 1 Hs.54089 120018 P311 P311 protein Hs.142827 103119 UBL4 ubiquitin-like 4 Hs.76480 118120 UGT2B15 UDP glycosyltransferase 2 family, polypeptide B15 Hs.150207 117770 Homo sapiens mRNA for Hmob33 protein, 3’ untranslated region Hs.153716 104513 Homo sapiens cDNA FLJ13549 fis, clone PLACE1007097 Hs.56406 110191 ARNT aryl hydrocarbon receptor nuclear translocator Hs.166172 112029 P2Y5 purinergic receptor family A group 5 Hs.189999 110188 ESTs Hs.40173 104717 CSNK1A1 casein kinase 1, alpha 1 Hs.283738 109568 HSPC144 HSPC144 protein Hs.13645 116425 PTPRM protein tyrosine phosphatase, receptor type, M Hs.154151 110330 Homo sapiens, clone IMAGE:3947276, mRNA, partial cds Hs.180178 98705 SLC38A2 solute carrier family 38, member 2 Hs.298275 111798 SLC38A2 solute carrier family 38, member 2 Hs.298275 103534 TRAP150 thyroid hormone receptor-associated protein, 150 kDa subunit Hs.108319 104272 TRAP150 thyroid hormone receptor-associated protein, 150 kDa subunit Hs.108319 110224 STX7 syntaxin 7 Hs.8906 102950 HTPAP HTPAP protein Hs.169341 119073 KIAA1117 KIAA1117 protein Hs.278398 104502 AGM1 N-acetylglucosamine-phosphate mutase Hs.237323 107912 SSR3 signal sequence receptor, gamma translocon-associated protein gamma Hs.28707 110996 DCN decorin Hs.76152 117688 HSD17B4 hydroxysteroid 17-beta dehydrogenase 4 Hs.75441 100095 PRO2730 hypothetical protein PRO2730 Hs.194110 108340 SEPP1 selenoprotein P, plasma, 1 Hs.3314 116278 Homo sapiens cDNA FLJ11660 fis, clone HEMBA1004610 Hs.281895 112782 SRP19 signal recognition particle 19kD Hs.2943 101508 SPHAR **S-phase response cyclin-related Hs.296169 108304 MAPK6 mitogen-activated protein kinase 6 Hs.271980 113276 MAPK6 mitogen-activated protein kinase 6 Hs.271980 114652 GG2-1 TNF-induced protein Hs.17839 117878 APPBP2 amyloid beta precursor protein cytoplasmic tail binding protein 2 Hs.84084 112672 DKFZp761J139 hypothetical protein DKFZp761J139 Hs.15536 109064 MDS006 x 006 protein Hs.47668 99977 ESTs Hs.356487 118688 ESTs Hs.356487 106544 SHMT2 **serine hydroxymethyltransferase 2 mitochondrial Hs.75069 111103 NAT1 N-acetyltransferase 1 arylamine N-acetyltransferase Hs.155956 110212 NAT1 N-acetyltransferase 1 arylamine N-acetyltransferase Hs.155956 99003 ESTs Hs.188697 107760 HMGCR 3-hydroxy-3-methylglutaryl-Coenzyme A reductase Hs.11899 104334 ELL2 ELL-related RNA polymerase II, elongation factor Hs.98124 102208 SDCBP syndecan binding protein syntenin Hs.8180 107848 MKLN1 muskelin 1, intracellular mediator containing kelch motifs Hs.288791 107090 LAMA4 laminin, alpha 4 Hs.78672 120603 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Hs.81328 103987 NPC1 Niemann-Pick disease, type C1 Hs.76918 111818 TBC1D1 TBC1 tre-2/USP6, BUB2, cdc16 domain family, member 1 Hs.278586 99408 KRT8 keratin 8 Hs.242463 101431 B4GALT1 **UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 Hs.198248 104534 DKFZP566I1024 DKFZP566I1024 protein Hs.279696 117937 KIAA1102 KIAA1102 protein Hs.202949 98784 AMD1 S-adenosylmethionine decarboxylase 1 Hs.262476 119447
Recommended publications
  • Transcriptomic Analysis of the Aquaporin (AQP) Gene Family

    Transcriptomic Analysis of the Aquaporin (AQP) Gene Family

    Pancreatology 19 (2019) 436e442 Contents lists available at ScienceDirect Pancreatology journal homepage: www.elsevier.com/locate/pan Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic markers in patients with pancreatic ductal adenocarcinoma Dimitrios E. Magouliotis a, b, Vasiliki S. Tasiopoulou c, Konstantinos Dimas d, * Nikos Sakellaridis d, Konstantina A. Svokos e, Alexis A. Svokos f, Dimitris Zacharoulis b, a Division of Surgery and Interventional Science, Faculty of Medical Sciences, UCL, London, UK b Department of Surgery, University of Thessaly, Biopolis, Larissa, Greece c Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece d Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece e The Warren Alpert Medical School of Brown University, Providence, RI, USA f Riverside Regional Medical Center, Newport News, VA, USA article info abstract Article history: Background: This study aimed to assess the differential gene expression of aquaporin (AQP) gene family Received 14 October 2018 interactome in pancreatic ductal adenocarcinoma (PDAC) using data mining techniques to identify novel Received in revised form candidate genes intervening in the pathogenicity of PDAC. 29 January 2019 Method: Transcriptome data mining techniques were used in order to construct the interactome of the Accepted 9 February 2019 AQP gene family and to determine which genes members are differentially expressed in PDAC as Available online 11 February 2019 compared to controls. The same techniques were used in order to evaluate the potential prognostic role of the differentially expressed genes. Keywords: PDAC Results: Transcriptome microarray data of four GEO datasets were incorporated, including 142 primary Aquaporin tumor samples and 104 normal pancreatic tissue samples.
  • Formation of COPI-Coated Vesicles at a Glance Eric C

    Formation of COPI-Coated Vesicles at a Glance Eric C

    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs209890. doi:10.1242/jcs.209890 CELL SCIENCE AT A GLANCE Formation of COPI-coated vesicles at a glance Eric C. Arakel1 and Blanche Schwappach1,2,* ABSTRACT unresolved, this review attempts to refocus the perspectives of The coat protein complex I (COPI) allows the precise sorting of lipids the field. and proteins between Golgi cisternae and retrieval from the Golgi KEY WORDS: Arf1, ArfGAP, COPI, Coatomer, Golgi, Endoplasmic to the ER. This essential role maintains the identity of the early reticulum, Vesicle coat secretory pathway and impinges on key cellular processes, such as protein quality control. In this Cell Science at a Glance and accompanying poster, we illustrate the different stages of COPI- Introduction coated vesicle formation and revisit decades of research in the Vesicle coat proteins, such as the archetypal clathrin and the coat context of recent advances in the elucidation of COPI coat structure. protein complexes II and I (COPII and COPI, respectively) are By calling attention to an array of questions that have remained molecular machines with two central roles: enabling vesicle formation, and selecting protein and lipid cargo to be packaged within them. Thus, coat proteins fulfil a central role in the 1Department of Molecular Biology, Universitätsmedizin Göttingen, Humboldtallee homeostasis of the cell’s endomembrane system and are the basis 23, 37073 Göttingen, Germany. 2Max-Planck Institute for Biophysical Chemistry, 37077 Göttingen, Germany. of functionally segregated compartments. COPI operates in retrieval from the Golgi to the endoplasmic reticulum (ER) and in intra-Golgi *Author for correspondence ([email protected]) transport (Beck et al., 2009; Duden, 2003; Lee et al., 2004a; Spang, E.C.A., 0000-0001-7716-7149; B.S., 0000-0003-0225-6432 2009), and maintains ER- and Golgi-resident chaperones and enzymes where they belong.
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
  • Supplementary Table 2

    Supplementary Table 2

    Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
  • Supplementary Material Computational Prediction of SARS

    Supplementary Material Computational Prediction of SARS

    Supplementary_Material Computational prediction of SARS-CoV-2 encoded miRNAs and their putative host targets Sheet_1 List of potential stem-loop structures in SARS-CoV-2 genome as predicted by VMir. Rank Name Start Apex Size Score Window Count (Absolute) Direct Orientation 1 MD13 2801 2864 125 243.8 61 2 MD62 11234 11286 101 211.4 49 4 MD136 27666 27721 104 205.6 119 5 MD108 21131 21184 110 204.7 210 9 MD132 26743 26801 119 188.9 252 19 MD56 9797 9858 128 179.1 59 26 MD139 28196 28233 72 170.4 133 28 MD16 2934 2974 76 169.9 71 43 MD103 20002 20042 80 159.3 403 46 MD6 1489 1531 86 156.7 171 51 MD17 2981 3047 131 152.8 38 87 MD4 651 692 75 140.3 46 95 MD7 1810 1872 121 137.4 58 116 MD140 28217 28252 72 133.8 62 122 MD55 9712 9758 96 132.5 49 135 MD70 13171 13219 93 130.2 131 164 MD95 18782 18820 79 124.7 184 173 MD121 24086 24135 99 123.1 45 176 MD96 19046 19086 75 123.1 179 196 MD19 3197 3236 76 120.4 49 200 MD86 17048 17083 73 119.8 428 223 MD75 14534 14600 137 117 51 228 MD50 8824 8870 94 115.8 79 234 MD129 25598 25642 89 115.6 354 Reverse Orientation 6 MR61 19088 19132 88 197.8 271 10 MR72 23563 23636 148 188.8 286 11 MR11 3775 3844 136 185.1 116 12 MR94 29532 29582 94 184.6 271 15 MR43 14973 15028 109 183.9 226 27 MR14 4160 4206 89 170 241 34 MR35 11734 11792 111 164.2 37 52 MR5 1603 1652 89 152.7 118 53 MR57 18089 18132 101 152.7 139 94 MR8 2804 2864 122 137.4 38 107 MR58 18474 18508 72 134.9 237 117 MR16 4506 4540 72 133.8 311 120 MR34 10010 10048 82 132.7 245 133 MR7 2534 2578 90 130.4 75 146 MR79 24766 24808 75 127.9 59 150 MR65 21528 21576 99 127.4 83 180 MR60 19016 19049 70 122.5 72 187 MR51 16450 16482 75 121 363 190 MR80 25687 25734 96 120.6 75 198 MR64 21507 21544 70 120.3 35 206 MR41 14500 14542 84 119.2 94 218 MR84 26840 26894 108 117.6 94 Sheet_2 List of stable stem-loop structures based on MFE.
  • Target Gene Gene Description Validation Diana Miranda

    Target Gene Gene Description Validation Diana Miranda

    Supplemental Table S1. Mmu-miR-183-5p in silico predicted targets. TARGET GENE GENE DESCRIPTION VALIDATION DIANA MIRANDA MIRBRIDGE PICTAR PITA RNA22 TARGETSCAN TOTAL_HIT AP3M1 adaptor-related protein complex 3, mu 1 subunit V V V V V V V 7 BTG1 B-cell translocation gene 1, anti-proliferative V V V V V V V 7 CLCN3 chloride channel, voltage-sensitive 3 V V V V V V V 7 CTDSPL CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like V V V V V V V 7 DUSP10 dual specificity phosphatase 10 V V V V V V V 7 MAP3K4 mitogen-activated protein kinase kinase kinase 4 V V V V V V V 7 PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) V V V V V V V 7 PPP2R5C protein phosphatase 2, regulatory subunit B', gamma V V V V V V V 7 PTPN4 protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) V V V V V V V 7 EZR ezrin V V V V V V 6 FOXO1 forkhead box O1 V V V V V V 6 ANKRD13C ankyrin repeat domain 13C V V V V V V 6 ARHGAP6 Rho GTPase activating protein 6 V V V V V V 6 BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 V V V V V V 6 BNIP3L BCL2/adenovirus E1B 19kDa interacting protein 3-like V V V V V V 6 BRMS1L breast cancer metastasis-suppressor 1-like V V V V V V 6 CDK5R1 cyclin-dependent kinase 5, regulatory subunit 1 (p35) V V V V V V 6 CTDSP1 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 V V V V V V 6 DCX doublecortin V V V V V V 6 ENAH enabled homolog (Drosophila) V V V V V V 6 EPHA4 EPH receptor A4 V V V V V V 6 FOXP1 forkhead box P1 V
  • Craniofacial Diseases Caused by Defects in Intracellular Trafficking

    Craniofacial Diseases Caused by Defects in Intracellular Trafficking

    G C A T T A C G G C A T genes Review Craniofacial Diseases Caused by Defects in Intracellular Trafficking Chung-Ling Lu and Jinoh Kim * Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA 50011, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-515-294-3401 Abstract: Cells use membrane-bound carriers to transport cargo molecules like membrane proteins and soluble proteins, to their destinations. Many signaling receptors and ligands are synthesized in the endoplasmic reticulum and are transported to their destinations through intracellular trafficking pathways. Some of the signaling molecules play a critical role in craniofacial morphogenesis. Not surprisingly, variants in the genes encoding intracellular trafficking machinery can cause craniofacial diseases. Despite the fundamental importance of the trafficking pathways in craniofacial morphogen- esis, relatively less emphasis is placed on this topic, thus far. Here, we describe craniofacial diseases caused by lesions in the intracellular trafficking machinery and possible treatment strategies for such diseases. Keywords: craniofacial diseases; intracellular trafficking; secretory pathway; endosome/lysosome targeting; endocytosis 1. Introduction Citation: Lu, C.-L.; Kim, J. Craniofacial malformations are common birth defects that often manifest as part of Craniofacial Diseases Caused by a syndrome. These developmental defects are involved in three-fourths of all congenital Defects in Intracellular Trafficking. defects in humans, affecting the development of the head, face, and neck [1]. Overt cranio- Genes 2021, 12, 726. https://doi.org/ facial malformations include cleft lip with or without cleft palate (CL/P), cleft palate alone 10.3390/genes12050726 (CP), craniosynostosis, microtia, and hemifacial macrosomia, although craniofacial dys- morphism is also common [2].
  • A Trafficome-Wide Rnai Screen Reveals Deployment of Early and Late Secretory Host Proteins and the Entire Late Endo-/Lysosomal V

    A Trafficome-Wide Rnai Screen Reveals Deployment of Early and Late Secretory Host Proteins and the Entire Late Endo-/Lysosomal V

    bioRxiv preprint doi: https://doi.org/10.1101/848549; this version posted November 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 A trafficome-wide RNAi screen reveals deployment of early and late 2 secretory host proteins and the entire late endo-/lysosomal vesicle fusion 3 machinery by intracellular Salmonella 4 5 Alexander Kehl1,4, Vera Göser1, Tatjana Reuter1, Viktoria Liss1, Maximilian Franke1, 6 Christopher John1, Christian P. Richter2, Jörg Deiwick1 and Michael Hensel1, 7 8 1Division of Microbiology, University of Osnabrück, Osnabrück, Germany; 2Division of Biophysics, University 9 of Osnabrück, Osnabrück, Germany, 3CellNanOs – Center for Cellular Nanoanalytics, Fachbereich 10 Biologie/Chemie, Universität Osnabrück, Osnabrück, Germany; 4current address: Institute for Hygiene, 11 University of Münster, Münster, Germany 12 13 Running title: Host factors for SIF formation 14 Keywords: siRNA knockdown, live cell imaging, Salmonella-containing vacuole, Salmonella- 15 induced filaments 16 17 Address for correspondence: 18 Alexander Kehl 19 Institute for Hygiene 20 University of Münster 21 Robert-Koch-Str. 4148149 Münster, Germany 22 Tel.: +49(0)251/83-55233 23 E-mail: [email protected] 24 25 or bioRxiv preprint doi: https://doi.org/10.1101/848549; this version posted November 19, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.
  • A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection

    A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection

    CLINICAL RESEARCH www.jasn.org A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection Weijia Zhang,1 Zhengzi Yi,1 Karen L. Keung,2 Huimin Shang,3 Chengguo Wei,1 Paolo Cravedi,1 Zeguo Sun,1 Caixia Xi,1 Christopher Woytovich,1 Samira Farouk,1 Weiqing Huang,1 Khadija Banu,1 Lorenzo Gallon,4 Ciara N. Magee,5 Nader Najafian,5 Milagros Samaniego,6 Arjang Djamali ,7 Stephen I. Alexander,2 Ivy A. Rosales,8 Rex Neal Smith,8 Jenny Xiang,3 Evelyne Lerut,9 Dirk Kuypers,10,11 Maarten Naesens ,10,11 Philip J. O’Connell,2 Robert Colvin,8 Madhav C. Menon,1 and Barbara Murphy1 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background In kidney transplant recipients, surveillance biopsies can reveal, despite stable graft function, histologic features of acute rejection and borderline changes that are associated with undesirable graft outcomes. Noninvasive biomarkers of subclinical acute rejection are needed to avoid the risks and costs associated with repeated biopsies. Methods We examined subclinical histologic and functional changes in kidney transplant recipients from the prospective Genomics of Chronic Allograft Rejection (GoCAR) study who underwent surveillance biopsies over 2 years, identifying those with subclinical or borderline acute cellular rejection (ACR) at 3 months (ACR-3) post-transplant. We performed RNA sequencing on whole blood collected from 88 indi- viduals at the time of 3-month surveillance biopsy to identify transcripts associated with ACR-3, developed a novel sequencing-based targeted expression assay, and validated this gene signature in an independent cohort.
  • Golgipathies in Neurodevelopment: a New View of Old Defects Sowmyalakshmi Rasika, Sandrine Passemard, Alain Verloes, Pierre Gressens, Vincent El Ghouzzi

    Golgipathies in Neurodevelopment: a New View of Old Defects Sowmyalakshmi Rasika, Sandrine Passemard, Alain Verloes, Pierre Gressens, Vincent El Ghouzzi

    Golgipathies in Neurodevelopment: A New View of Old Defects Sowmyalakshmi Rasika, Sandrine Passemard, Alain Verloes, Pierre Gressens, Vincent El ghouzzi To cite this version: Sowmyalakshmi Rasika, Sandrine Passemard, Alain Verloes, Pierre Gressens, Vincent El ghouzzi. Golgipathies in Neurodevelopment: A New View of Old Defects. Developmental Neuroscience, Karger, 2019, 40 (5-6), pp.396-416. 10.1159/000497035. hal-02322665 HAL Id: hal-02322665 https://hal.archives-ouvertes.fr/hal-02322665 Submitted on 2 Jun 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Rasika et al, Golgipathies and Neurodevelopment 1 2 Golgipathies in Neurodevelopment: 3 A New View of Old Defects 4 5 1,2 1,2 1,2 6 Sowmyalakshmi Rasika , Sandrine Passemard , Alain Verloes , Pierre 1,3 1* 7 Gressens , Vincent El Ghouzzi 8 9 1. PROTECT, INSERM, Université Paris Diderot, Sorbonne Paris Cité, Paris, France 10 2. AP HP, Hôpital Robert Debré, UF de Génétique Clinique, Paris, France 11 3. Centre for the Developing Brain, Division of Imaging Sciences and Biomedical 12 Engineering, King’s College London, King’s Health Partners, St. Thomas’ Hospital, 13 London, United Kingdom 14 15 *Corresponding author: 16 Vincent El Ghouzzi 17 Address: Inserm U1141, Hôpital Robert-Debré, 48 Boulevard Sérurier, F-75019, 18 Paris, France.
  • Induction of Therapeutic Tissue Tolerance Foxp3 Expression Is

    Induction of Therapeutic Tissue Tolerance Foxp3 Expression Is

    Downloaded from http://www.jimmunol.org/ by guest on October 2, 2021 is online at: average * The Journal of Immunology , 13 of which you can access for free at: 2012; 189:3947-3956; Prepublished online 17 from submission to initial decision 4 weeks from acceptance to publication September 2012; doi: 10.4049/jimmunol.1200449 http://www.jimmunol.org/content/189/8/3947 Foxp3 Expression Is Required for the Induction of Therapeutic Tissue Tolerance Frederico S. Regateiro, Ye Chen, Adrian R. Kendal, Robert Hilbrands, Elizabeth Adams, Stephen P. Cobbold, Jianbo Ma, Kristian G. Andersen, Alexander G. Betz, Mindy Zhang, Shruti Madhiwalla, Bruce Roberts, Herman Waldmann, Kathleen F. Nolan and Duncan Howie J Immunol cites 35 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2012/09/17/jimmunol.120044 9.DC1 This article http://www.jimmunol.org/content/189/8/3947.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of October 2, 2021.
  • Program in Human Neutrophils Fails To

    Program in Human Neutrophils Fails To

    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 is online at: average * The Journal of Immunology Anaplasma phagocytophilum , 20 of which you can access for free at: 2005; 174:6364-6372; ; from submission to initial decision 4 weeks from acceptance to publication J Immunol doi: 10.4049/jimmunol.174.10.6364 http://www.jimmunol.org/content/174/10/6364 Insights into Pathogen Immune Evasion Mechanisms: Fails to Induce an Apoptosis Differentiation Program in Human Neutrophils Dori L. Borjesson, Scott D. Kobayashi, Adeline R. Whitney, Jovanka M. Voyich, Cynthia M. Argue and Frank R. DeLeo cites 28 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2005/05/03/174.10.6364.DC1 This article http://www.jimmunol.org/content/174/10/6364.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* • Why • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Insights into Pathogen Immune Evasion Mechanisms: Anaplasma phagocytophilum Fails to Induce an Apoptosis Differentiation Program in Human Neutrophils1 Dori L.